Total Intravenous Anesthesia vs Spinal Anesthesia in Patients Undergoing Unilateral Primary Total Knee Arthroplasty
1 other identifier
interventional
150
1 country
1
Brief Summary
The purpose of this study is to compare same-day discharge rates and recovery outcomes across an adult patient population undergoing elective Total Knee Arthroplasty (TKA), and randomized to receive either spinal block anesthesia or Total IntraVenous Anesthesia (TIVA). Primary Aim: assess same-day discharge rates between study arms (TIVA vs spinal). Secondary Aim: Postoperative comparison of recovery during PostOperative Anesthesia Care Unit (PACU) admission, diagnostic assessment scores; outcomes related to cognition, hemodynamic stability, pain, nausea and vomiting; analysis of IntraOperative electroencephalogram (EEG) monitoring metrics, e.g., total suppression time, average Bi-spectral Index monitor (BIS) value, Spectral Edge Frequency (SEF); ability for Physical Therapy (PT) evaluation prior to discharge; longterm-followup (LTFU), hospital readmission, return to surgery, etc.; adverse event (AE) monitoring.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Mar 2026
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 11, 2026
CompletedFirst Submitted
Initial submission to the registry
June 8, 2026
CompletedFirst Posted
Study publicly available on registry
June 26, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2028
June 26, 2026
June 1, 2026
1.2 years
June 8, 2026
June 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Compare Same-Day Discharge (SDD) Rates
Comparison of same-day discharge rates between patients receiving either total intravenous anesthesia (TIVA) or spinal-block anesthesia, during total knee arthroplasty (TKA).
at PostOperative (Day-0)
Secondary Outcomes (9)
Post-Anesthesia Care Unit (PACU) Length of Admission
at PostOperative (Day-0)
Changes in Short Portable Mental Status Questionnaire (SPMSQ)
at PreOperative (Baseline), PostOperative (Day-0), PostOperative (Day-1)
Changes in 3-Minute Diagnostic Assessment for Confusion Assessment Method (3D-CAM)
at PreOperative (Baseline), PostOperative (Day-0), PostOperative (Day-1)
Changes in Numeric Rating Scale (NRS) score, Nausea
at PostOperative (Day-0) and PostOperative (Day-1)
Monitor changes in Numeric Pain Rating Scale (NPRS) score
at PostOperative (Day-0) and PostOperative (Day-1)
- +4 more secondary outcomes
Study Arms (2)
Arm A -Total IntraVenous Anesthesia (TIVA) with Electroencephalogram (EEG)
ACTIVE COMPARATORArm A (TIVA): Induction and maintenance intravenously (propofol, dexmedetomidine, fentanyl, hydromorphone); no volatile agents. Anesthetic depth titration based on clinical responsiveness, hemodynamic and ventilatory parameters, and processed electroencephalogram (EEG) monitoring.
Arm B - Spinal Block with Electroencephalogram (EEG)
ACTIVE COMPARATORArm B (Spinal): Single-shot intrathecal mepivacaine-2%, 3.0 milliliters (mL) per institutional standard. Light propofol sedation is permitted at clinician discretion, titrated to comfort and clinical responsiveness, hemodynamic and ventilatory parameters, and processed electroencephalogram (EEG) monitoring.
Interventions
Total IntraVenous Anesthesia - to achieve deep-sedation via chemical analgesic (propofol, dexmedetomidine, fentanyl, hydromorphone); continuous intravenous infusion.
Spinal-block (mepivacaine 2%, 3.0 mL) Clinician discretion to administer light-sedation with intravenously infused propofol during surgery.
Non-invasive continuous neurological (Neuro) monitoring device, e.g., Bi-spectral (BIS), recording electrical activity of the brain via adhesive scalp electrodes, which transmit neuro-activity during sedation.
Eligibility Criteria
You may qualify if:
- Adults aged ≥18 years.
- Scheduled to undergo elective primary total knee arthroplasty (TKA) or robotic total knee arthroplasty (TKA) at the University of Chicago.
- Eligible for same-day discharge (SDD) based on established orthopedic and anesthesia criteria.
- Able to provide written informed consent.
- The ability to comprehend and complete cognitive assessment surveys and questionnaires.
- Consent to receive either Total IntraVenous Anesthesia (TIVA) or Spinal-block Anesthesia in a randomized manner
- No contraindication to either TIVA or spinal anesthesia
You may not qualify if:
- Age \<18 years.
- Patients undergoing revision TKA or procedures other than elective primary TKA.
- Ineligibility for same-day discharge as determined by the surgical or anesthesia team.
- Contraindications to either anesthetic technique (e.g., spinal block anesthesia contraindicated due to coagulopathy, infection at puncture site, or patient refusal).
- Known allergy or hypersensitivity to study-related medications.
- Significant pre-existing cognitive impairment or dementia that would preclude valid participation in Short Portable Mental Status Questionnaire (SPMSQ), and 3-Minute Diagnostic Assessment for Confusion Assessment Method (3D-CAM) assessments.
- Severe chronic pain syndromes (e.g., fibromyalgia, centrally mediated pain disorders) that could confound perioperative pain assessment.
- Body mass index (BMI) \> 40.
- Prisoners or other vulnerable populations unable to provide voluntary consent.
- Unable to give appropriate consent or difficult to comprehend and complete cognitive assessment surveys and questionnaires
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Chicago Medical Center
Chicago, Illinois, 60637, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zheng Xie, MD, PhD
University of Chicago, Department of Anesthesia and Critical Care
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 8, 2026
First Posted
June 26, 2026
Study Start
March 11, 2026
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
June 1, 2028
Last Updated
June 26, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE
- Time Frame
- De-identified data may be shared adhoc at the discretion of the principal investigator, following completion of study enrollment and data analysis.
- Access Criteria
- Only researchers and statisticians at the University of Chicago may have access to any shared de-identified study data.
Per institutional regulation, and at the discretion of Principal Investigator, de-identified data may be shared with researcher(s) at the University of Chicago.